Response to Hu et al
Am J Gastroenterol
.
2017 Feb;112(2):383-384.
doi: 10.1038/ajg.2016.549.
Authors
Yi-Wen Huang
1
2
3
4
,
An-Chi Hsieh
1
,
Sien-Sing Yang
1
5
Affiliations
1
Liver Center, Cathay General Hospital Medical Center, Taipei, Taiwan.
2
School of Medicine, Taipei Medical University College of Medicine, Taipei, Taiwan.
3
Department of Internal Medicine, Division of Gastroenterology, National Taiwan University College of Medicine, Taipei, Taiwan.
4
School of Medicine, China Medical University, Taichung, Taiwan.
5
School of Medicine, Fu-Jen Catholic University College of Medicine, Taipei, Taiwan.
PMID:
28154397
DOI:
10.1038/ajg.2016.549
No abstract available
Publication types
Comment
MeSH terms
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Liver Cirrhosis*
Risk
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors